ALEXANDRIA, Va., May 26 -- United States Patent no. 12,637,716, issued on May 26, was assigned to Myriad Genetics Inc. (Salt Lake City).
"Detecting cancer risk" was invented by Elisha Hughes (Salt Lake City) and Alexander Gutin (Salt Lake City).
According to the abstract* released by the U.S. Patent & Trademark Office: "Methods, kits, and systems for assessing the risk of a human subject for developing a cancer, including genetic risk assessment, clinical risk assessment, and combinations of both to improve risk analysis. Technologies utilize, among other things, analyzing a sample of DNA obtained or derived from a subject to detect the genotype for a plurality of test genomic loci."
The patent was filed on June 1, 2018, under Applicatio...